WeiTang Partners with Ping An Health Insurance to Launch 'Ping An GlucoCare' for Chronic Disease Management

VCBeat has learned that the diabetes management platformWeTang partners with Ping An Health Insurance,In recent daysPublishofDiabetes Complications Insurance Product“Ping An Blood Sugar Control Insurance”，and in WeiTangFormalLaunched. This productIntegratedLeveraging Ping An Health Insurance’s strengths in chronic disease medical insurance and Wei Tang’s service advantages in comprehensive diabetes management, we provide diabetic patients with more convenient, comprehensive, and innovative insurance coverage and end-to-end management services.

Diabetes has become one of the most challenging public health issues in China, with a grim situation. According to data from the China Healthcare Security Association and the International Diabetes Federation (IDF), the prevalence of diabetes in China is 11.6%, affecting 114 million people, among whom more than 90% (over 100 million) have type 2 diabetes. Furthermore, recent survey data indicate that the prevalence rate among adults aged 35 and above in Shanghai’s permanent resident population is 17.65%. Based on this estimate, there are approximately 2 million diabetic patients in Shanghai, imposing a substantial disease burden.

From the perspective of patients with diabetes, there is currently a lack of effective interventions for diabetes treatment. Poor glycemic control can easily lead to complications, including neuropathy, hypertension, renal failure, retinopathy, heart disease, and peripheral vascular disease of the lower extremities. According to data from China Investment Consultant, which analyzed 3,469 hospitalized patients with type 2 diabetes across ten hospitals in four regions—including Shanghai, Tianjin, and Chongqing—between 1991 and 2010, diabetic neuropathy was found to be the most common complication. Diabetic nephropathy occurred in 20%–40% of patients, while approximately 35% of patients developed diabetic retinopathy.

For patients with diabetes, there is an urgent need for targeted health insurance coverage to achieve stable blood glucose control and prevent complications. It is understood that there are currently no healthcare plans on the market that truly meet the needs of diabetic patients. First, there are numerous enrollment restrictions, such as stringent underwriting criteria that exclude smokers and individuals in certain high-risk occupations. Second, coverage does not align with patient needs; for instance, common acute complications are excluded, and daily expenses for hypoglycemic medications and medical supplies are not reimbursed. Third, services fail to deliver effective outcomes, lacking professional and efficient follow-up care.

To help patients better manage their blood glucose health, WeTang and Ping An Health Insurance have jointly launched the “Ping An Glucose Control Insurance” protection plan, which provides one-stop, personalized, end-to-end management services for blood glucose and other health indicators. Its core highlights include coverage for reimbursement of glucose-lowering medications, devices, and consumables not listed in the national medical insurance catalog. In addition, “Ping An Glucose Control Insurance” covers hospitalization expenses for three major acute complications—diabetic ketoacidosis, hyperglycemic hyperosmolar syndrome, and diabetic lactic acidosis—as well as diagnosis and treatment costs for seven major chronic complications, including blindness, amputation, and kidney failure.

“Few comparable products provide coverage for acute complications, yet patients frequently develop these three major categories of symptoms due to misconceptions about medication use. Ping An’s Diabetes Control Insurance offers annual inpatient coverage of RMB 10,000 for acute diabetic complications. One-time surgical costs for end-stage complications can range from RMB 30,000 to RMB 200,000, exposing patients to significant financial risk from high medical expenses. Ping An’s Diabetes Control Insurance covers seven major complications, with benefit amounts ranging from RMB 50,000 to RMB 100,000,” explained a relevant representative from Ping An Health Insurance.

Tailored to each patient’s individual circumstances, Weitang’s professional medical “glucose control” team provides customized treatment “packages”: specialist physicians devise treatment plans; diabetes education nurses deliver patient education, conduct routine follow-ups, and address disease-related concerns; and registered dietitians provide personalized dietary plans and develop exercise regimens. Together, they implement a comprehensive strategy for stable glucose management through pharmacotherapy, health education, and lifestyle interventions.

Notably, “Ping An Blood Sugar Control Insurance” integrates online and offline services to provide patients with more convenient, comprehensive, and innovative full-course diabetes management. Its partner, WeTang, offers offline assessment services for patients with type 2 diabetes, including comprehensive complication risk screening. Leveraging big data analytics, its risk engine can calculate the five-year risk of severe complications in diabetic patients, such as coronary heart disease, stroke, heart failure, and renal failure.

Huang Dacheng, President of WeiTang Medical Services, stated to VCBeat: “The American Diabetes Association and the European Association for the Study of Diabetes jointly recommend that individuals with diabetes undergo a comprehensive diabetes risk assessment every 12 to 18 months. Following years of clinical trials in Hong Kong, WeiTang has now taken the lead in introducing this diabetes risk assessment framework to China. WeiTang’s risk assessment engine meets the diabetes care standards established by the International Diabetes Federation (IDF). Based on the assessment results, patients can understand their risks for various complications and develop appropriate treatment plans. Through a multidisciplinary medical team, treatment regimens are adjusted and patients are assisted in modifying their lifestyle habits, thereby helping high-risk populations and individuals with diabetes reduce the likelihood of future complications.”